Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Lecture outline
- Macrophages - general attributes
- Macrophages and receptor recognition
- CD36 structure
- CD36: regions within the protein
- CD36: function and membrane distribution
- CD36: a multifunctional membrane glycoprotein (1)
- CD36: a multifunctional membrane glycoprotein (2)
- Atherogenesis and monocytes/macrophages
- A tale of two mice
- Experimental design of atherosclerosis in mice
- The aortic tree in mice and humans
- Absence of CD36 & atherosclerosis in apoEo mice
- ApoEo vs. ApoEo/CD36o: degree of lesions
- Lesions in LDLRo mice are not CD36 dependent
- LDLRo vs. LDLRo/CD36o lesion burden
- Foam cell formation in LDLRo is CD36 dependent
- CD36 may not be the atherogenic ligand in LDLRo
- In vivo foam cell assay
- The ligand in the 2 mouse models differs
- Ligand may differ in a CD36 dependent manner
- Making the LDL in the LDLRo a ligand for CD36
- LDLRo vs. CD36o/LDLRo + high cholesterol diet
- LDLR KO's: hyperlipidemia and inflammation
- Inflammation, CD36 ligands and atherosclerosis
- CD36 specific ligands in oxidatively modified LDL
- CD36 ligands are choline glycerophospholipids
- How CD36 detects differences in phospholipids
- Multiple pathways may create CD36R ligands
- Recognition of altered self ligands by CD36
- Summary
- Acknowledgements
Topics Covered
- Scavenger receptors
- Structure of CD36
- Role of CD36
- The link between inflammation and CD36
- Risk factors for inflammation
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Febbraio, M. (2013, January 30). Macrophage CD36 and atherosclerosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/LVLM9718.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Maria Febbraio has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.